Ethic Inc. Boosts Stock Position in HCA Healthcare, Inc. $HCA

Ethic Inc. lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 72.8% during the third quarter, HoldingsChannel reports. The firm owned 16,529 shares of the company’s stock after purchasing an additional 6,966 shares during the quarter. Ethic Inc.’s holdings in HCA Healthcare were worth $7,045,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Park Place Capital Corp increased its position in shares of HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after buying an additional 1,168 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in HCA Healthcare by 11.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after acquiring an additional 2,698 shares during the period. Swiss National Bank boosted its holdings in HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after purchasing an additional 23,100 shares during the period. Cherokee Insurance Co bought a new position in shares of HCA Healthcare in the second quarter worth $3,869,000. Finally, Harrell Investment Partners LLC grew its position in HCA Healthcare by 176.3% during the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after buying an additional 1,158 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.7%

NYSE HCA opened at $473.79 on Tuesday. The stock has a 50-day moving average of $476.47 and a 200-day moving average of $421.52. The firm has a market cap of $108.12 billion, a PE ratio of 18.31, a price-to-earnings-growth ratio of 1.41 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the previous year, the company posted $4.90 earnings per share. The business’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. The Goldman Sachs Group lifted their price target on HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research report on Monday, October 27th. TD Cowen increased their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Truist Financial upped their target price on shares of HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Wells Fargo & Company raised their price objective on HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a report on Thursday, November 13th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $479.00.

Insider Transactions at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.